Stay updated with breaking news from John Teijaro. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Enveda Biosciences, a biotechnology company also known as Enveda Therapeutics Inc. that uses artificial intelligence to develop new medicines, has formed a therapeutic advisory board to advise the company as it enters clinical trials this year.
Scientists from Scripps Research have developed a small molecule that blocks the activity of a protein linked to autoimmune diseases, including systemic lupus erythematosus (SLE) and Crohn's disease.
<p>Scripps Research scientists developed a compound that can block a protein previously considered challenging to drug and is implicated in autoimmune diseases, including lupus.</p>
/PRNewswire/ -- A collaborative scientific team led by researchers at the Applied Biomedical Science Institute (ABS), Scripps Research, Kansas State University...
Versant Ventures-backed Belharra Therapeutics has launched with $130 million in funding and a partnership with Roche subsidiary Genentech. The startup’s technology analyzes proteins in the context of the entire cell, enabling it to discover molecules that bid to targets previously deemed undruggable.